Business Context and Reporting Period
This Form 8-K filing by Bioflamex Corporation (noting a discrepancy with the requested "Cann American Corp." name) covers the event date of December 28, 2012. The registrant is incorporated in Nevada with principal executive offices in Charlottenlund, Denmark.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
The primary material change reported is a 40:1 Reverse Stock Split. Key details include:
- Approval: FINRA approved the split on December 28, 2012.
- Effective Date: The market effective date is December 31, 2012.
- Corporate Action: Amendments to the Articles of Incorporation were filed with the State of Nevada following approval by the Board of Directors and a majority of stockholders.
- Trading Symbol: The stock symbol BFLX will be suffixed with a "D" for 20 business days, after which it will revert to the original symbol.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on future operations, specific risks, contingencies, or unusual items beyond the administrative details of the stock split.
Investor Verification Checklist
- Verify the correct registrant name (Bioflamex Corporation vs. Cann American Corp.) and ticker symbol status.
- Confirm the effective date of the 40:1 reverse stock split on December 31, 2012.
- Monitor the trading symbol for the "D" suffix duration (20 business days).
- Review the amended Articles of Incorporation filed with the State of Nevada.